Keyphrases
Cisplatin
100%
Induced Apoptosis
100%
Autophagy
100%
Skin Carcinoma
100%
Cisplatin-induced
100%
Skin Cancer
50%
Knock
50%
AKT Inhibition
50%
MET1
50%
Tumor Progression
25%
Cancer Development
25%
Cell Death
25%
Keratinocytes
25%
Phosphoinositide 3-kinase (PI3K)
25%
Protein Markers
25%
Fluorescence Microscopy
25%
3-methyladenine (3-MA)
25%
Therapeutic Agents
25%
Combination Therapy
25%
Good Prognosis
25%
Lymph Node Metastasis
25%
Caucasian Population
25%
Cutaneous Squamous Cell Carcinoma (cSCC)
25%
Cutaneous SCC
25%
Skin Tumor
25%
Therapeutic Benefits
25%
Common Cancers
25%
Enhanced Resistance
25%
Electron Microscopy
25%
Maturation Stage
25%
Apoptosis Resistance
25%
Enhanced Cytotoxicity
25%
LC3-II
25%
ATG5
25%
Phagosome Maturation
25%
Resistance to Chemotherapy
25%
Chemoresistance
25%
AKT1
25%
Autophagy-related Proteins
25%
Autophagy Pathway
25%
Autophagic
25%
Cancer Resistance
25%
Forehead Skin
25%
Immunocompromised Patients
25%
Advanced Cutaneous Squamous Cell Carcinoma
25%
Akt Activation
25%
Malignant Transformation
25%
Isogenic Cell Lines
25%
Primary Cutaneous
25%
GFP Fluorescence
25%
AKT Inhibitor
25%
AKT Pathway
25%
Curability
25%
Medicine and Dentistry
Programmed Cell Death
100%
Cisplatin
100%
Autophagy
100%
Protein Kinase B
100%
Skin Carcinoma
100%
Skin Cancer
33%
Cancer
16%
Tumor Progression
16%
Antiinfective Agent
16%
Cell Death
16%
Combination Therapy
16%
Maturation
16%
3 Methyladenine
16%
Autophagosome
16%
Cell Line
16%
Lymph Node Metastasis
16%
Skin Tumor
16%
Cytotoxicity
16%
Fluorescence Microscopy
16%
Electron Microscopy
16%
Drug Resistance
16%
Malignant Transformation
16%
Keratinocyte
16%
Biochemistry, Genetics and Molecular Biology
Protein Kinase B
100%
Cisplatin
100%
Autophagy
100%
Programmed Cell Death
100%
Cytotoxicity
16%
Tumor Progression
16%
Cell Death
16%
Keratinocyte
16%
Maturation
16%
Electron Microscopy
16%
Drug Resistance
16%
Autophagosome
16%
Malignant Transformation
16%
ATG5
16%
AKT1
16%
Fluorescence Microscopy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Protein Kinase B
100%
Skin Carcinoma
100%
Skin Cancer
33%
Tumor Growth
16%
Antiinfective Agent
16%
Chemotherapy
16%
Combination Therapy
16%
Skin Tumor
16%
Malignant Transformation
16%
Fluorescence Microscopy
16%
Drug Resistance
16%
Lymph Node Metastasis
16%
Electron Microscopy
16%
3 Methyladenine
16%
Cytotoxicity
16%
Immunology and Microbiology
Autophagy
100%
Programmed Cell Death
100%
Squamous Cell
50%
Cytotoxicity
25%
Cell Death
25%
Maturation
25%
Keratinocyte
25%
Cell Line
25%
Lymph Node
25%
Drug Resistance
25%
Electron Microscopy
25%
Autophagosome
25%
ATG5
25%
Fluorescence Microscopy
25%